Pharma says new Phase 3 trial of trontinemab wil
Author: Michael
EyePoint Pharmaceuticals announced it has complet
Novos announced the release of the Novos Bar, des
Learn the potential risks of exercising outside wh
Selective removal of toxic cholesterol restores
OncoC4 presents data indicating immunotherapy ha
Promis Neurosciences announced a non-brokered pri
Carmat has received MDR CE marking for its Aeson
Bryan Johnson pivots from CEO to philosophical fi
Klotho Neuro to continue work in neurology while